NEW YORK & NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Verona Pharma plc (NasdaqGM: VRNA) to Merck & Co., Inc. (NYSE: MRK). Under the terms of the proposed transaction, shareholders of Verona will receive $107.00 in cash for each share of American Depository Share that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-vrna/ to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
CONNECT WITH US: Facebook || Instagram || YouTube || TikTok || LinkedIn
Contacts
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-855-768-1857
1100 Poydras St., Suite 960
New Orleans, LA 70163
HomeInherit Logo NEW YORK, Oct. 11, 2025 (GLOBE NEWSWIRE) -- HomeInherit today announced an investment…
October 10, 2025 16:41 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO, Oct. 10, 2025…
New York City, NY, Oct. 11, 2025 (GLOBE NEWSWIRE) -- Introduction In 2025, artificial intelligence…
New York City, NY, Oct. 11, 2025 (GLOBE NEWSWIRE) -- In a competitive era where…
LOS ANGELES--(BUSINESS WIRE)--The DJS Law Group announces that it is investigating claims on behalf of…
LOS ANGELES--(BUSINESS WIRE)--$SFIX--The Schall Law Firm, a national shareholder rights litigation firm, announces that it…
